The Exchange has sought clarification from Alembic Pharmaceuticals on April 18, 2016 with reference to the news appeared in www.indiainfoline.com stating, Alembic Pharma tanks 7% US FDA makes four observations.
The above information is a part of company’s filings submitted to BSE.